TRVN Company Profile and Key Details

Q: Who are the executives of TRVN?

Ms. Carrie L. BourdowPres, Chief Executive Officer & DirectorMr. Michael CatalanoVice President of MarketingMr. Barry ShinSenior Vice President & Chief Financial OfficerMs. Patricia M. DrakeSenior Vice President & Chief Commercial OfficerMr. Joel SolomonVice President, Gen. Counsel & Chief Compliance OfficerMr. Robert T. YoderSenior Vice President, Chief Bus. Officer & Head of Commercial OperationsDr. Mark A. DemitrackSenior Vice President & Chief Medical OfficerDr. Howard A. Rockman M.D.Scientific Founder, Consultant and Member of Scientific Advisory Board

NASDAQ : TRVN

Trevena

$0.00

0.0001+33.33%

At Close 4:00 PM

69.17

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Trevena, Inc. (TRVN) stock surged +33.33%, trading at $0.00 on OTC, up from the previous close of $0.00. The stock opened at $0.00, fluctuating between $0.00 and $0.00 in the recent session.

Stock Snapshot

0.0003

Prev. Close

346

Market Cap

0.0004

Day Low

N/A

P/E Ratio

-48.89

EPS (TTM)

-2.7

Cash Flow per Share

Open

863.79K

Number of Shares

0.0004

Day High

97.85%

Free Float in %

0.25

Book Value

214

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 11, 2026	0.00	0.00	0.00	0.00	214
Sep 09, 2026	0.00	0.00	0.00	0.00	346
Aug 26, 2026	0.00	0.00	0.00	0.00	1.22K
Aug 17, 2026	0.00	0.00	0.00	0.00	109
Aug 05, 2026	0.00	1.50	0.00	0.00	1.84K
Jul 20, 2026	0.01	0.01	0.01	0.01	185
Jul 17, 2026	0.01	0.01	0.01	0.01	355
Jul 09, 2026	0.01	0.01	0.01	0.01	654
Jun 26, 2026	0.00	0.00	0.00	0.00	275
Jun 25, 2026	0.00	0.00	0.00	0.00	559
Jun 24, 2026	0.00	0.00	0.00	0.00	424
Jun 16, 2026	0.01	0.01	0.01	0.01	1.53K
Jun 12, 2026	0.00	0.00	0.00	0.00	145
Jun 04, 2026	0.01	0.01	0.01	0.01	965
May 29, 2026	0.00	0.00	0.00	0.00	447
May 27, 2026	0.00	0.00	0.00	0.00	308
May 06, 2026	0.01	0.01	0.01	0.01	1.38K
Apr 29, 2026	0.01	0.01	0.01	0.01	114
Apr 28, 2026	0.01	0.01	0.01	0.01	215
Apr 20, 2026	0.01	0.01	0.01	0.01	831

Contact Details

Chesterbrook, PA 19087

United States

https://www.trevena.com 610 354 8840

About Company

Trevena, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing innovative pharmaceutical solutions for individuals suffering from central nervous system disorders. Its pipeline features several promising drug candidates: OLINVYK (Oliceridine) injection: A G protein-biased mu-opioid receptor (MOR) ligand engineered to manage acute pain ranging from moderate to severe. TRV027: Aimed at addressing acute lung injury, which contributes to acute respiratory distress syndrome (ARDS) and abnormal blood clotting in patients with COVID-19. TRV250: A G protein-biased delta-opioid receptor agonist under development for the treatment of acute migraine. TRV734: A small molecule G protein-biased MOR ligand designed for the management of both moderate-to-severe acute and chronic pain. TRV045: An innovative S1P modulator focused on providing relief for chronic pain. The company has also established a partnership with Imperial College London to investigate TRV027's potential in patients afflicted with COVID-19. Trevena, Inc., founded in 2007, operates from its headquarters in Chesterbrook, Pennsylvania.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current Trevena, Inc. (TRVN) stock price?

Trevena, Inc. (OTC: TRVN) stock price is $0.00 in the last trading session. During the trading session, TRVN stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in TRVN stock occurred in the recent session was 33.33% while the dollar amount for the price change in TRVN stock was $0.00.

TRVN's industry and sector of operation?

The OTC listed TRVN is part of Biotechnology industry that operates in the broader Healthcare sector. Trevena, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TRVN?

Ms. Carrie L. Bourdow
Pres, Chief Executive Officer & Director
Mr. Michael Catalano
Vice President of Marketing
Mr. Barry Shin
Senior Vice President & Chief Financial Officer
Ms. Patricia M. Drake
Senior Vice President & Chief Commercial Officer
Mr. Joel Solomon
Vice President, Gen. Counsel & Chief Compliance Officer
Mr. Robert T. Yoder
Senior Vice President, Chief Bus. Officer & Head of Commercial Operations
Dr. Mark A. Demitrack
Senior Vice President & Chief Medical Officer
Dr. Howard A. Rockman M.D.
Scientific Founder, Consultant and Member of Scientific Advisory Board

How TRVN did perform over past 52-week?

TRVN's closing price is 33.33% higher than its 52-week low of $0.00 where as its distance from 52-week high of $1.93 is -99.98%.

How many employees does TRVN have?

Number of TRVN employees currently stands at 23.

Link for TRVN official website?

Official Website of TRVN is: https://www.trevena.com

How do I contact TRVN?

TRVN could be contacted at phone 610 354 8840 and can also be accessed through its website. TRVN operates from 955 Chesterbrook Boulevard, Chesterbrook, PA 19087, United States.

How many shares of TRVN are traded daily?

TRVN stock volume for the day was 214 shares. The average number of TRVN shares traded daily for last 3 months was 734.

What is the market cap of TRVN currently?

The market value of TRVN currently stands at $346.00 with its latest stock price at $0.00 and 863.79K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	23
Beta	-0.41
Sales or Revenue	-$418.00K
5Y Sales Change%	1.171%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	23
Beta	-0.41
Sales or Revenue	-$418.00K
5Y Sales Change%	1.171%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

TRVN Company Profile and Key Details

Trevena

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Technical Performance

Company Overview

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways